(Reuters) -Eli Lilly will acquire privately held SiteOne Therapeutics, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain drug.
(Reporting by Sriparna Roy in Bengaluru; Editing by Devika Syamnath)
Eli Lilly to acquire privately held SiteOne
Comments